ANPEP and cancer: The pharmacological inhibition of APN/CD13 stimulates CSCs apoptosis [64] and has been shown to increase the antitumor effects of chemotherapeutic agents, e.g., 5-fluorouracil [148,167], which is why APN/CD13 inhibitors are considered cancer chemosensitizers [168].